AI-driven genomics startups leverage technology to analyze genetic data, predict predispositions, and offer personalized ...

A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

The genetic testing results also inform patients’ family members about their cancer risks so they can be proactive in screening and prevention. For now, GENETECA™ is only available to people with ...

Health systems across the country are making it easier for primary care clinicians to order genetic tests for patients who ...

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...

Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.

A pioneer in genetic heritage services, 23andMe has seen much of its share price wiped out in the past year as it struggles ...

Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...